RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties

← Drug Reference

Methylergonovine

routine management of uterine atony, hemorrhage and subinvolution of the uterus, control of uterine hemorrhage in the second stage of labor

Indications

  • routine management of uterine atony, hemorrhage and subinvolution of the uterus
  • control of uterine hemorrhage in the second stage of labor

Adult dosing

  • im injection: dose: 0.2; unit: mg; route: IM; interval: after delivery of anterior shoulder or placenta, every 2-4 hours; fixed: true; labelExcerpt: Intramuscularly 1 mL, 0.2 mg, after delivery of the anterior shoulder, after delivery of the placenta, or during the puerperium. May be repeated as required, at intervals of 2 to 4 hours.
  • iv injection: dose: 0.2; unit: mg; route: IV; interval: single dose; fixed: true; labelExcerpt: Intravenously 1 mL, 0.2 mg, administered slowly over a period of no less than 60 seconds
  • oral puerperium: dose: 0.2; unit: mg; route: PO; interval: 3 or 4 times daily for max 1 week; fixed: true; labelExcerpt: Orally The recommended dosage of methylergonovine maleate is One tablet, 0.2 mg, orally 3 or 4 times daily in the puerperium for a maximum of 1 week.

Pediatric dosing

  • Consult pharmacy/current label

Renal adjustment

  • Consult pharmacy/current label

Hepatic adjustment

  • Caution should be exercised in the presence of impaired hepatic function.

Contraindications

  • Hypertension
  • Toxemia
  • Pregnancy
  • Hypersensitivity

Clinical pearls

  • Do not administer IV routinely due to risk of sudden hypertensive or cerebrovascular accidents.
  • If IV administration is essential, inject slowly over at least 60 seconds with blood pressure monitoring.
  • Store separately from neonatal medications to prevent accidental infant administration.
  • Patients with coronary artery disease may be at increased risk of myocardial ischemia.

Source and review

  • DailyMed label (methylergonovine maleate), Set ID 4ddcdfff-1468-bff0-e063-6294a90a5480, effective 2026-03-25. Last reviewed: 2026-11-11